Social and clinical vulnerability in stroke and STEMI management during the COVID-19 pandemic: a registry-based study

Autor: Jérome Berge, Gaultier Marnat, Emmanuel Ellie, Igor Sibon, Basile Ondze, Ludovic Lucas, Xavier Combes, Catherine Pradeau, Pierre Coste, Jean-Luc Banos, Nicolas Delarche, François Rouanet, Pierre Fournier, Patricia Bernady, David Higue, Julie Péron, Stephanie Bannier, Virginie Heydel, Nathalie Goulois, Francois Orcival, Stephanie Vandentorren, Jean-Louis Leymarie, Bernard Karsenty, Emilie Lesaine, Sandrine Domecq, Laura Cetran, Sahal Miganeh-Hadi, Floriane Sevin, Stéphanie Demasles, Régis Hubrecht, Florence Francis, Florence Saillour, Jean Faucheux, Elena Leca Radu, Gaëlle Seignolles, Cécile Chazalon, Maria Dan, Laurent Wong-So, Miquel Martinez, Claire Nocon, Véronique Hostyn, Jérémy Papin, Philippe Bordier, Philippe Casenave, Laurent Maillard, Isabelle Argacha, Eliane Tidahy, Lucie Ferraton, Yousra Mostefai, Djoumana Bakpa, Christine Bartou, Catherine Goze-Dupuy, Hélène Lavocat, Frédéric Senis, Virginie Delonglee, Didier Darraillans, Tarak Mokni, Bertrand Bataille, Jean Lorendeau, Anncy Eclancher, Bruno Trogoff, Véronique Chartroule, Philippe Touchard, Hervé Leyral, Fogue Ngounou, Catherine Scouarnec, Bertrand Tahon, Emmanuel Py, Sorina Bidian, Jean Fabre, Nidhal Cherhabil, Leila Baha, Pierre-Arnaud Fort, Vincent Maisonnave, Luc Verhoeven, Paul Claveries, Emma Ansart, Brice Lefevre, Marie-Pierre Liepa, Marc Lacrouts, Jean-Baptiste Coustere, Philippe Jarnier, Nicolas Marque, Jean-Marie Perron, Akil Hassan, Francois Casteigt, Bernard Larnaudie, Guillaume Laplace

Publikováno v: BMJ Open, Vol 14, Iss 1 (2024)

Objective This study aims to evaluate whether the first wave of the COVID-19 pandemic resulted in a deterioration in the quality of care for socially and/or clinically vulnerable stroke and ST-segment elevation myocardial infarction (STEMI) patients.

Externí odkaz: https://doaj.org/article/b114a006d4cc468489a9dee0f93583ca

Comparison of outcomes in patients with or without ARC-HBR criteria undergoing PCI with polymer-free biolimus coated stents: The BioFreedom France study

Autor: Philippe, Garot, Philippe, Brunel, Alain, Dibie, Jean-François, Morelle, Mohamed, Abdellaoui, Raphy, Levy, Didier, Carrié, Bernard, Karsenty, Christophe, Robin, Jacques, Berland, Samuel, Copt, Sara, Sadozai Slama, Keith, Oldroyd, Marie-Claude, Morice, Janusz, Lipiecki

Publikováno v: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventionsREFERENCES.

The polymer-free biolimus coated stent (BioFreedom) was shown to be superior to bare metal stents in the LEADERS FREE randomized trial in high bleeding risk (HBR) patients treated with 1-month dual antiplatelet therapy (DAPT). However, there is limit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a8613016233b9ec0627307052206cbe
https://pubmed.ncbi.nlm.nih.gov/36378683

Safety and efficacy outcomes of 3rd generation DES in an all-comer population of patients undergoing PCI: 12-month and 24-month results of the e-Biomatrix French registry

Autor: Thierry Lefèvre, Janusz Lipiecki, Raphy Levy, Marc Eric Moulichon, Bernard Karsenty, Luc Maillard, François Brunelle, Eric Maupas, Fabien de Poli, Benjamin Faurie

Publikováno v: Catheterization and Cardiovascular Interventions. 90:890-897

Objectives The French Ebiomatrix registry aimed to confirm the results of the Leaders trial in an all-comer population in France. Background The Leaders trial showed the Biolimus-eluting-sent (BES) to be equivalent to the Cypher stent in terms of saf

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::13b53f5d9763b57f895a932aaeb0312b
https://doi.org/10.1002/ccd.27081

French Ministry of Health prospective multicentre study using bio-active stents coated with titanium nitride oxide: the EVIDENCE registry

Autor: Frederic Collet, Bernard Karsenty, Christophe Loubeyre, Antoine Gommeaux, Paul Barragan, Patrick Dupouy, Olivier Wittenberg, Gérard Finet, Philippe Durand, Xavier Tabone, Jean Fajadet, Thierry Unterseeh, Pierre Meyer, Marie-Claude Morice, Marc Silvestri, Benoit Gerardin, Simon Cattan, Michael Angioi, Jean-Marc Lablanche, Marc-Éric Moulichon, Smain Sayah

Publikováno v: Archives of cardiovascular diseases. 105(2)

Summary Background Coronary stents have evolved over time, from bare-metal stents to drug-eluting stents, and now to bioactive stents. Aims We sought to explore the immediate outcome of the titanium-nitride-oxide-coated bioactive stent, Titan2 ® , i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73baa1b3fc93d64488fdd4aa5e8288aa
https://pubmed.ncbi.nlm.nih.gov/22424323